SBC Medical Group Is Fired Up And Ready For Growth In The New Year
From expanding the number of clinics to setting its sights on new markets, it's been a busy year for SBC Medical Group Holdings Inc. (NASDAQ:SBC), the Japanese owner and operator of a chain of aesthetic medical clinics. The company made a lot of moves during the year that it says puts it in a position for growth in 2026.To address competition and keep its leading position in the industry, SBC pursued two strategies: expanding the market by making aesthetic medicine more accessible and differentiating itself from the competition by offering advanced treatments and better pricing. Those initiatives both paid off, enabling it to expand the number of clinics, boost repeat business and enhance customer loyalty.Highlights for 2025 included the following:The number of franchise locations is now 258, representing a 15% Y-o-Y increase as of 09/30/2025.Revised pricing led to the average revenue per customer increasing 5% in 3Q25, fueled by pricing optimization and adding higher revenue-generating customers through its multi-brand strategyNew services which SBC expects will strengthen its position and market share within the aesthetic and specialized medical care areas. Clinics in the SBC franchise network have expanded their offerings to encompass a broad range of specialized medical services, including plastic surgery and infertility treatment. International expansion to Singapore and Thailand, and in early 2026, announced the first expansion in the U.S.Launched a new brand, "Neo Skin Clinic" and "Hada no Aozora Clinic" in Tokyo. Hada no Aozora clinics use a hybrid dermatology model integrating insurance-covered general dermatology and private-pay aesthetic treatments. Acquired "MB Career Lounge Co. Ltd.", which is a privately held provider of management support services for medical institutions, specializing in consulting, training and human resources solutions Acquired a related subsidiary of SBC, Waqoo, to help accelerate Waqoo's R&D and integrate its technologies and expertise to enhance its offerings in clinical areas such as AGA and orthopedics, develop new treatments and services, and strengthen SBC's competitive position. The companies will also jointly develop and promote skincare products.Added to the Russell 3000 IndexSBC Medical's Year Of Change This past spring, recognizing it was in a position to capitalize on the fragmented aesthetics market in Japan, SBC Medical made a big push to grow its business, leveraging its ...Full story available on Benzinga.com
